BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

Compounds That Target ANKK1

ankyrin repeat and kinase domain containing 1 · 18 compounds in BiohacksAI corpus

ANKK1 (ankyrin repeat and kinase domain containing 1) is a biological target with 18 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into ANKK1 modulation for therapeutic and biohacking applications.

Most Studied Compounds for ANKK1
298+
studies
298+
studies
All 18 Compounds — Ranked by Evidence
1
Foretinib
4.34
confidence
2
Tozasertib
4.33
confidence
3
Ruxolitinib
4.23
confidence
4
Bosutinib
4.08
confidence
5
Doramapimod
4.06
confidence
6
Tae 684
3.43
confidence
7
Fedratinib
3.40
confidence
8
Dovitinib
3.09
confidence
9
Jnj 7706621
3.09
confidence
10
Lestaurtinib
3.04
confidence
11
Defosbarasertib
2.89
confidence
12
R 406
2.83
confidence
13
Kw 2449
2.64
confidence
14
Ast 487
2.56
confidence
15
Gsk 461364
2.40
confidence
16
Su 014813
2.20
confidence
298+
studies
0.69
confidence
298+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for ANKK1 (ankyrin repeat and kinase domain containing 1). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: ANKK1 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.